Geron Corporation - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
GERN Nasdaq 2834 www.geron.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Geron Corporation

Geron to Participate in the 7th Annual Evercore ISI HealthCONx Conference - Nov 27th, 2024 2:00 pm
Geron Corp. (GERN): Among the NASDAQ Stocks with Biggest Upside Potential According to Analysts - Nov 22nd, 2024 12:11 pm
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Nov 21st, 2024 9:30 pm
High Growth Tech Stocks to Watch in November 2024 - Nov 21st, 2024 6:02 pm
Geron Corporation Announces Appointment of Joseph Eid, M.D. as Executive Vice President, Research and Development - Nov 11th, 2024 9:30 pm
Geron to Participate in the Stifel 2024 Healthcare Conference - Nov 11th, 2024 2:00 pm
Analysts Are Upgrading Geron Corporation (NASDAQ:GERN) After Its Latest Results - Nov 10th, 2024 1:56 pm
Geron Third Quarter 2024 Earnings: Beats Expectations - Nov 9th, 2024 12:15 pm
Geron Corp (GERN) Q3 2024 Earnings Call Highlights: Strong Rytelo Launch and Strategic ... - Nov 8th, 2024 1:00 pm
Geron Secures $250M Funding and Strong Q3 Sales - Nov 8th, 2024 12:29 pm
Tezspire succeeds in chronic rhinosinusitis; Gilead writes down Trodelvy value - Nov 8th, 2024 10:00 am
Geron (GERN) Q3 2024 Earnings Call Transcript - Nov 7th, 2024 9:30 pm
Geron Secures up to $375 Million in Funding with Royalty Pharma, Pharmakon Advisors - Nov 7th, 2024 4:42 pm
Geron (GERN) Reports Q3 Loss, Tops Revenue Estimates - Nov 7th, 2024 1:20 pm
Geron: Q3 Earnings Snapshot - Nov 7th, 2024 12:14 pm
Royalty Pharma to Acquire Royalty Interest in Geron’s RYTELO for $125 Million - Nov 7th, 2024 12:10 pm
Geron Corporation Announces Up to $375 Million in Funding with Royalty Pharma and Pharmakon Advisors - Nov 7th, 2024 12:01 pm
Geron Corporation Reports Third Quarter 2024 Financial Results and Recent Business Highlights - Nov 7th, 2024 12:00 pm
Geron Announces New Data to be Presented at Upcoming ASH Annual Meeting Highlighting the Potential of RYTELO™ (imetelstat) in Myeloid Hematologic Malignancies - Nov 5th, 2024 2:00 pm
Is Geron Corporation (GERN) the Hottest Penny Stock to Invest in According to Hedge Funds? - Oct 16th, 2024 1:06 pm